M&A Deal Summary |
|
|---|---|
| Date | 2023-01-23 |
| Target | Appletree CI Group |
| Sector | Business Services |
| Buyer(s) | TFS International |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 750 |
| Revenue | 49M EUR (2015) |
TFS International is a contract research organization (CRO) that supports pharmaceutical companies throughout the clinical development process. TFS focuses its scientific and medical expertise through a broad spectrum of industry-leading experts in dermatology, oncology, and hematology. TFS International was established in 1996 and is based in Lund, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 6 of 6 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-10-07 |
SCIderm
Hamburg, Germany SCIderm GmbH is a specialized CRO in dermatology. SCIderm provides a unique range of services and offers execution of dermatology trials, quality-tested study sites and process coordination with the SCIderm in-house clinic. SCIderm is providing access to opinion leaders and 350 investigational sites in Europe and North America to meet any trial requirement need in dermatology. |
Buy | - |
